• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《中国癌症统计数据 2015》

Cancer statistics in China, 2015.

机构信息

Deputy Director, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China.

Associate Researcher, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China.

出版信息

CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.

DOI:10.3322/caac.21338
PMID:26808342
Abstract

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000-2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (-1.4% per year; P < .05) and females (-1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.

摘要

在中国,癌症发病率和死亡率不断上升,已成为主要的公共卫生问题。由于中国人口众多(13.7 亿),之前的全国发病率和死亡率估计仅限于使用 20 世纪 90 年代的数据或基于特定年份的小样本人群。随着中国国家癌症中心现有的更多基于人群的登记处提供高质量的数据,作者分析了来自 72 个地方、基于人群的癌症登记处(2009-2011 年)的数据,这些登记处代表了 6.5%的人口,以估计 2015 年的新发病例和癌症死亡人数。22 个登记处的数据用于趋势分析(2000-2011 年)。结果表明,2015 年中国预计将有 429.2 万例新发癌症病例和 281.4 万例癌症死亡,肺癌是最常见的癌症,也是癌症死亡的主要原因。胃癌、食管癌和肝癌也很常见,被确定为癌症死亡的主要原因。农村居民的所有癌症合并年龄标准化(塞吉人口)发病率和死亡率均显著高于城市居民(发病率分别为每 10 万人 213.6 例和 191.5 例;死亡率分别为每 10 万人 149.0 例和 109.5 例)。在所有癌症中,2000 年至 2011 年期间,男性的发病率保持稳定(每年增长 0.2%;P = .1),而女性的发病率显著增加(每年增长 2.2%;P < .05)。相比之下,自 2006 年以来,男性(每年下降 1.4%;P < .05)和女性(每年下降 1.1%;P < .05)的死亡率均显著下降。通过降低危险因素的流行率,提高临床护理的有效性,特别是对生活在农村地区和弱势群体的人,可以预防许多估计的癌症病例和死亡。

相似文献

1
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
2
[Analysis of cancer incidence and mortality in elderly population in China, 2013].[2013年中国老年人群癌症发病率与死亡率分析]
Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):60-66. doi: 10.3760/cma.j.issn.0253-3766.2017.01.012.
3
[Report of Cancer Incidence and Mortality in China, 2014].《2014年中国癌症发病与死亡报告》
Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):5-13. doi: 10.3760/cma.j.issn.0253-3766.2018.01.002.
4
[Incidence and mortality of stomach cancer in China, 2013].《2013年中国胃癌的发病率与死亡率》
Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):547-552. doi: 10.3760/cma.j.issn.0253-3766.2017.07.015.
5
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
6
[The incidence and mortality of lung cancer in China, 2014].[2014年中国肺癌的发病率和死亡率]
Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002.
7
Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.2004 - 2013年美国非都市和都市县的侵袭性癌症发病率以及2006 - 2015年的死亡情况
MMWR Surveill Summ. 2017 Jul 7;66(14):1-13. doi: 10.15585/mmwr.ss6614a1.
8
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
9
[Estimation of cancer incidence and mortality in China in 2004-2005].[2004 - 2005年中国癌症发病率与死亡率估算]
Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):664-8.
10
Cancer incidence and mortality: A cohort study in China, 2008-2013.癌症发病率和死亡率:中国 2008-2013 年的队列研究。
Int J Cancer. 2017 Oct 1;141(7):1315-1323. doi: 10.1002/ijc.30825. Epub 2017 Jun 26.

引用本文的文献

1
PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.PRMT1介导的PARP1甲基化通过激活三阴性乳腺癌中的P65驱动肺转移和化疗耐药性。
Research (Wash D C). 2025 Sep 8;8:0854. doi: 10.34133/research.0854. eCollection 2025.
2
Impact of Clonorchis sinensis infection on long-term survival after curative resection for hepatocellular carcinoma: A multicenter cohort study.华支睾吸虫感染对肝细胞癌根治性切除术后长期生存的影响:一项多中心队列研究。
PLoS Negl Trop Dis. 2025 Sep 4;19(9):e0013441. doi: 10.1371/journal.pntd.0013441. eCollection 2025 Sep.
3
Mechanistic Study on the Inhibitory Effect of Dandelion Extract on Breast Cancer Cell Proliferation and Its Induction of Apoptosis.
蒲公英提取物对乳腺癌细胞增殖的抑制作用及其诱导凋亡的机制研究
Biology (Basel). 2025 Jul 22;14(8):910. doi: 10.3390/biology14080910.
4
Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021.1990年至2036年东亚5国胃癌负担及未来趋势:利用2021年全球疾病负担研究进行的流行病学研究分析
JMIR Cancer. 2025 Sep 3;11:e74389. doi: 10.2196/74389.
5
FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathway.FAM49B通过激活PI3K/AKT信号通路介导胃癌的肿瘤进展和不良预后。
J Mol Histol. 2025 Sep 3;56(5):291. doi: 10.1007/s10735-025-10589-y.
6
Development and Validation of a Nomogram for Prognostic Prediction in Ovarian Cancer Based on Tumor Proliferation and Immune-Related Biomarkers in Chinese Patients.基于中国患者肿瘤增殖和免疫相关生物标志物的卵巢癌预后预测列线图的开发与验证
Int J Womens Health. 2025 Aug 25;17:2661-2670. doi: 10.2147/IJWH.S517367. eCollection 2025.
7
CT Radiomics-based machine learning approach for the invasiveness of pulmonary ground-glass nodules prediction.基于CT影像组学的机器学习方法用于预测肺磨玻璃结节的侵袭性
Eur J Radiol Open. 2025 Aug 23;15:100680. doi: 10.1016/j.ejro.2025.100680. eCollection 2025 Dec.
8
Applications and prospects of spatial transcriptomics in prostate cancer research: A narrative review.空间转录组学在前列腺癌研究中的应用与前景:一篇叙述性综述。
Curr Urol. 2025 Sep;19(5):303-308. doi: 10.1097/CU9.0000000000000288. Epub 2025 May 23.
9
Mechanisms for fibrate lipid-lowering drugs in enhancing bladder cancer immunotherapy by inhibiting CD276 expression.贝特类降脂药物通过抑制CD276表达增强膀胱癌免疫治疗的机制。
BMC Cancer. 2025 Sep 1;25(1):1404. doi: 10.1186/s12885-025-14855-w.
10
The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients.癌症治疗对乳腺癌患者长期心理结局和生活质量的影响。
BMC Cancer. 2025 Aug 30;25(1):1403. doi: 10.1186/s12885-025-14667-y.